• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OLYMPUS MEDICAL SYSTEMS CORP. EVIS LUCERA DUODENOVIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OLYMPUS MEDICAL SYSTEMS CORP. EVIS LUCERA DUODENOVIDEOSCOPE Back to Search Results
Model Number TJF-260V
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Fistula (1862); Pancreatitis (4481); Liver Failure (4492); Unspecified Hepatic or Biliary Problem (4493)
Event Date 09/09/2018
Event Type  Injury  
Manufacturer Narrative
This supplemental report is being sent to provide the author's opinion regarding the relatedness of the olympus device and adverse events.New information was added.
 
Event Description
The author provided additional information: dr.(b)(6) does not think there is a possibility the olympus device contributed to the reported adverse events.
 
Manufacturer Narrative
The suspect device has not been returned to olympus for evaluation.The investigation is in process.Once the investigation has been completed, a supplemental report will be submitted with device evaluation results.
 
Event Description
Olympus reviewed the following literature titled "effect of mapping biopsy on surgical management of cholangiocarcinoma" by kojiro taura et al.This retrospective study aimed to evaluate the role of endoscopic transpapillary mapping biopsy (mb) in determining the surgical indication and procedure, and its effect on surgical radicality regarding the bile duct (bd) margin for cholangiocarcinoma (cca) patients.A total of 115 mb procedures were performed in 80 patients who underwent tumor resection.The study reported that 60 (75.0%) patients tolerated mb without any complications except pancreatitis observed in 20 (25.0%) patients.The incidence of bile leakage was significantly lower in the mb group in both the anastomotic site (5.0% vs.16.3%) and the parenchymal surface.The study concluded mb was safe and efficacious in selecting optimal surgical procedures for cholangiocarcinoma.The authors used multiple olympus devices and did not specify the devices used in relation to the adverse events experienced.Therefore, all olympus devices will be reported for the following adverse events: postoperatively, patients had mild, moderate and severe pancreatitis, post-hepactectomy liver failure, bile leakage at the anastomotic site, the parenchymal surface, and at a pancreatic fistula.This article includes 5 reports.(b)(6) - tjf-240 (b)(6) - tjf-260 (b)(6) - fb-45q-1 (b)(6) - e634044 (b)(6) - chf-b260 this is report 1 of 5 for: (b)(6) tjf-240.
 
Manufacturer Narrative
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation.The device history record was unable to be reviewed for this device since the lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the relationship between the device and the adverse event cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Olympus will continue to monitor field performance for this device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVIS LUCERA DUODENOVIDEOSCOPE
Type of Device
DUODENOVIDEOSCOPE
Manufacturer (Section D)
OLYMPUS MEDICAL SYSTEMS CORP.
2951 ishikawa-cho
hachioji-shi, tokyo-to 192-8 507
JA  192-8507
Manufacturer Contact
kazutaka matsumoto
2951 ishikawa-cho
hachioji-shi, tokyo-to 192-8-507
JA   192-8507
426425177
MDR Report Key13543575
MDR Text Key290475015
Report Number8010047-2022-03044
Device Sequence Number1
Product Code FDS
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 05/25/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/16/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberTJF-260V
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received04/27/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
FB-45Q-1 OR E634044, CHF-B260.
Patient Outcome(s) Other;
-
-